Cite
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
MLA
Neurologen, et al. Disease Activity in Patients with Immune-Mediated Inflammatory Diseases after SARS-CoV-2 Vaccinations. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1457899613&authtype=sso&custid=ns315887.
APA
Neurologen, Brain, van Dam, K. P. J., Wieske, L., Stalman, E. W., Kummer, L. Y. L., Roosen, J., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Boekel, L., Wolbink, G. J., van der Kooi, A. J., Raaphorst, J., Löwenberg, M., Takkenberg, R. B., D’Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., … the T2B! Immunity against SARS-CoV-2 study group. (2023). Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
Chicago
Neurologen, Brain, Koos P.J. van Dam, Luuk Wieske, Eileen W. Stalman, Laura Y.L. Kummer, Jesse Roosen, et al. 2023. “Disease Activity in Patients with Immune-Mediated Inflammatory Diseases after SARS-CoV-2 Vaccinations.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1457899613&authtype=sso&custid=ns315887.